Table 5.

Demographic data of patients that achieved control using treatment with either montelukast or fluticasone.

Studied parameters	Controlled Cases Montelukast (%)	Controlled Cases Fluticasone (%)	P
Age
<10 Years	88.8	30.3	0.006*
>10 Years	11.2	69.7
Sex
Male	13.3	41.6	0.005*
Female	86.7	58.4
Asthma-free days per week	7	7
Asthma phenotypes
Cough phenotype	86	20	0.005*
SOB phenotype	15	80
Family history of asthma
Positive	88.8	25	0.006*
Negative	11.2	75
Body mass index (kg/m2)
<20%	100	75	0.333
20–25%	0	8.4
>25%	0	16.6
Duration
<5 Years	55.5	25
5–10 Years	33.3	58.4	0.006*
>10 Years	11.2	16.6
Eosinophilic% before treatment
Mean + SD	8.0 + 2.0	7 + 2.9	0.19
Median	8.0	6.0

*P significant <0.05.